Google Ad

First a part of phase-1 of Covaxin human trial accomplished at PGI Rohtak – Home Health Choices

Rohtak: The first a part of phase-1 of Covaxin human trial accomplished on Saturday at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, mentioned Dr Savita Verma, principal investigator of the vaccine trial crew.

Speaking to ANI, Dr Verma mentioned that six individuals have been administered the vaccine on Saturday below the second a part of phase-1.

“First part of phase-1 of vaccine trial (Covaxin) has been completed. 50 people across India were administered the vaccine and the results were encouraging. Six people were administered vaccine on Saturday under second part of phase-1,” she mentioned.

Human trials of Covaxin, India’s first vaccine candidate towards coronavirus, started at PGI Rohtak on July 17. Three volunteers have been administered Covaxin on that day.

Follow and join with us on , Facebook, Linkedin

Latest Updates

Related Post